Polysaccharides 2021
DOI: 10.1002/9781119711414.ch31
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic Polysaccharide‐Based Vaccines: Progress and Achievements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 75 publications
0
1
0
Order By: Relevance
“…It has been proposed that, in contrast to switched memory B cells that embody the highly specific adaptive memory, IgM memory B cells may instead act as a first line of defense [ 29 ]. Capsular polysaccharides are T cell-independent B cell antigens, and due to their capacity to induce protective antibody responses, are used for vaccination [ 30 , 90 ]. In fact, an altered response to polysaccharide vaccines, as well as an increased susceptibility to bacterial infections has been described in different groups of people with a reduced frequency of IgM memory B cells, e.g., newborns [ 30 , 31 , 42 , 46 , 47 , 91 , 92 ], congenitally asplenic and splenectomized individuals [ 29 , 46 ] or patients with common variable immunodeficiency [ 47 , 93 ].…”
Section: Discussionmentioning
confidence: 99%
“…It has been proposed that, in contrast to switched memory B cells that embody the highly specific adaptive memory, IgM memory B cells may instead act as a first line of defense [ 29 ]. Capsular polysaccharides are T cell-independent B cell antigens, and due to their capacity to induce protective antibody responses, are used for vaccination [ 30 , 90 ]. In fact, an altered response to polysaccharide vaccines, as well as an increased susceptibility to bacterial infections has been described in different groups of people with a reduced frequency of IgM memory B cells, e.g., newborns [ 30 , 31 , 42 , 46 , 47 , 91 , 92 ], congenitally asplenic and splenectomized individuals [ 29 , 46 ] or patients with common variable immunodeficiency [ 47 , 93 ].…”
Section: Discussionmentioning
confidence: 99%